Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia

Last updated: April 18, 2024
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heartburn (Pediatric)

Colic

Heartburn

Treatment

Dietary modifications

Clinical Study ID

NCT05810168
STH20655c
  • Ages 18-60
  • All Genders

Study Summary

Functional dyspepsia is common, affecting 7.2% of the global population, and associated with substantial health impairment. Almost 80% of patients with functional dyspepsia report meal-related symptoms and are classified as having the postprandial distress syndrome (PDS) variant. However, studies evaluating dietary modifications in PDS are sparse.

The investigators will perform a randomised trial evaluating traditional dietary advice (TDA) vs. a diet low in fermentable fermentable oligo-, di-, mono- saccharides and polyols (low FODMAP diet) in PDS.

70 patients with PDS will be randomly assigned TDA or a low FODMAP diet. The TDA group will be recommended to eat small, regular meals and reduce the intake of caffeine/alcohol/fizzy drinks, fatty/processed/spicy foods, and fibre. The low FODMAP diet group will be advised to exclude fermentable carbohydrates, which are present in wheat-based products, many fruits/vegetables, pulses, beans, dairy, and sweeteners.

Questionnaires are to be completed during the 6-week trial, including self-reported adequate relief of dyspeptic symptoms, and the validated Leuven Postprandial Distress Scale (LPDS), Gastrointestinal Symptom Rating Scale, and Nepean Dyspepsia Quality of Life Index.

The primary endpoint to define clinical response will be evaluated over weeks 4-6 as >0.5-point reduction in the PDS subscale of the LPDS (calculated as the mean scores for early satiety, postprandial fullness, and upper abdominal bloating).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Fulfil Rome IV symptoms criteria for postprandial functional dyspepsia
  • Normal upper gastrointestinal endoscopy within last 3years
  • Online access
  • English literate

Exclusion

Exclusion Criteria:

  • Organic gastrointestinal diseases (e.g. inflammatory bowel disease, GI cancer, coeliacdisease)
  • Major abdominal surgery (except laparoscopy, appendectomy, cholecystectomy)
  • Documented H.pylori in the last 3 months
  • History of eating disorders
  • Body mass index <20
  • Current dietary interventions
  • Current use of opioids or anti-inflammatory drugs
  • Severe systemic disease (e.g. cardiac, renal, respiratory) necessitating frequentmedical consultations)
  • Pregnant
  • Diabetes mellitus
  • Scleroderma
  • Memory impairment

Study Design

Total Participants: 70
Treatment Group(s): 1
Primary Treatment: Dietary modifications
Phase:
Study Start date:
August 30, 2023
Estimated Completion Date:
May 31, 2026

Connect with a study center

  • Royal Hallamshire Hospital

    Sheffield, South Yorkshire S10 2JF
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.